Tibial neuropathy

disease
On this page

Also known as tibial neuropathy (disorder) [ambiguous]

Summary

Tibial neuropathy (MONDO:0006997) is a disease and 2 clinical trials. A subtype of mononeuropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nametibial neuropathy
Mondo IDMONDO:0006997
MeSHD020429
DOIDDOID:1187
SNOMED CT399076001
UMLSC0751932
MedGen148422
Is cancer (heuristic)no

Also known as: tibial neuropathy (disorder) [ambiguous]

Disease family

This is a subtype of mononeuropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorderperipheral nervous system disorderperipheral neuropathymononeuropathytibial neuropathy

Related subtypes (6): radial neuropathy, mononeuritis simplex, peroneal neuropathy, femoral neuropathy, sciatic neuropathy, ulnar neuropathy

Subtypes (1): tarsal tunnel syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified2

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07048431Not specifiedNOT_YET_RECRUITINGTibial Nerve Elastography in Chemotherapy-Induced Neuropathic Pain
NCT01394822Not specifiedCOMPLETEDNeuromuscular Ultrasound for Focal Neuropathies

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.